Table 1.
Baseline Characteristics
Patient characteristics | Surgical Era
|
p value | ||
---|---|---|---|---|
Early (n = 309) | Middle (n = 316) | Current (n = 259) | ||
Age (years; median, IQR) | 59 (48–71) | 57 (49–71) | 59 (50–68) | 0.90 |
Female | 109 (35.3%) | 95 (30.1%) | 97 (37.5%) | 0.15 |
Hypertension | 250 (80.9%) | 258 (81.7%) | 203 (80.6%) | 0.94 |
Diabetes | 29 (3.4%) | 46 (14.6%) | 34 (13.6%) | 0.12 |
ESRD | 8 (9.0%) | 5 (1.6%) | 1 (0.4%) | <0.0001 |
Peripheral arterial disease | 39 (12.6%) | 47 (14.9%) | 46 (18.9%) | 0.13 |
Cerebrovascular disease | 31 (10.0%) | 33 (10.4%) | 36 (15.1%) | 0.13 |
Prior cerebrovascular accident | 16 (5.3%) | 15 (4.9%) | 26 (10.9%) | 0.01 |
Chronic lung disease, moderate/severe | 23 (7.4%) | 24 (7.6%) | 11 (5.2%) | 0.51 |
Coronary artery disease | 30 (9.7%) | 26 (8.2%) | 24 (9.3%) | 0.80 |
Prior myocardial infarction | 7 (9.7%) | 29 (9.2%) | 20 (8.1%) | 0.87 |
Heart failure within 2 weeks | 25 (8.1%) | 26 (8.2%) | 26 (10.7%) | 0.51 |
LVEF (%; median, IQR) | 55 (45–60) | 55 (50–60) | 57 (53–60) | 0.20 |
Aortic insufficiency, moderate/severe | 56 (18.5%) | 58 (20.7%) | 85 (37.6%) | <0.0001 |
Mitral insufficiency, moderate/severe | 11 (3.6%) | 12 (4.6%) | 4 (2.1%) | 0.36 |
Prior cardiac surgery | 37 (12.2%) | 38 (12.1%) | 22 (8.5%) | 0.29 |
Transfer patient | † | 44 (60.3%) | 139 (53.7%) | 0.32 |
Not captured in STS database during this era
CABG = Coronary artery bypass graft; ESRD = End Stage Renal Disease on Hemodialysis